Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.
J Hepatol. 2019 Jan 04;:
Splenectomy as Flow Modulation Strategy and Risk Factors of De-novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplant.
Liver Transpl. 2018 Aug 26;:
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.
Exp Clin Transplant. 2018 Apr 04;:
Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review.
Melanoma Res. 2017 Nov 14;:
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
Transpl Int. 2017 Jul 07;:
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.
Transplant Direct. 2017 Jun;3(6):e158
Transpl Infect Dis. 2017 Mar 22;:
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Ann Surg Oncol. 2017 Feb 03;:
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
Transplantation. 2016 Mar 4;